These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17491025)

  • 21. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.
    Mouillac B; Mendre C
    Handb Exp Pharmacol; 2018; 245():63-83. PubMed ID: 28939971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus.
    Marr N; Bichet DG; Hoefs S; Savelkoul PJ; Konings IB; De Mattia F; Graat MP; Arthus MF; Lonergan M; Fujiwara TM; Knoers NV; Landau D; Balfe WJ; Oksche A; Rosenthal W; Müller D; Van Os CH; Deen PM
    J Am Soc Nephrol; 2002 Sep; 13(9):2267-77. PubMed ID: 12191971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor.
    Krause G; Hermosilla R; Oksche A; Rutz C; Rosenthal W; Schülein R
    Mol Pharmacol; 2000 Feb; 57(2):232-42. PubMed ID: 10648632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrogenic diabetes insipidus.
    Morello JP; Bichet DG
    Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus.
    Tsukaguchi H; Matsubara H; Inada M
    Kidney Int; 1995 Aug; 48(2):554-62. PubMed ID: 7564126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG; Turner M; Morin D
    Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vasopressin receptors: structure/function relationships and signal transduction in target cells].
    Robert J; Clauser ER
    J Soc Biol; 2005; 199(4):351-9. PubMed ID: 16738530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.
    Morello JP; Salahpour A; Laperrière A; Bernier V; Arthus MF; Lonergan M; Petäjä-Repo U; Angers S; Morin D; Bichet DG; Bouvier M
    J Clin Invest; 2000 Apr; 105(7):887-95. PubMed ID: 10749568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.
    Sangkuhl K; Römpler H; Busch W; Karges B; Schöneberg T
    Hum Mutat; 2005 May; 25(5):505. PubMed ID: 15841479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic diabetes insipidus.
    Bichet DG
    Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues.
    Schülein R; Zühlke K; Oksche A; Hermosilla R; Furkert J; Rosenthal W
    FEBS Lett; 2000 Jan; 466(1):101-6. PubMed ID: 10648821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
    Morin D
    Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
    Bernier V; Morello JP; Zarruk A; Debrand N; Salahpour A; Lonergan M; Arthus MF; Laperrière A; Brouard R; Bouvier M; Bichet DG
    J Am Soc Nephrol; 2006 Jan; 17(1):232-43. PubMed ID: 16319185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics.
    Mendre C; Mouillac B
    Adv Protein Chem Struct Biol; 2019; 118():249-272. PubMed ID: 31928727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin receptor mutations in nephrogenic diabetes insipidus.
    Bichet DG
    Semin Nephrol; 2008 May; 28(3):245-51. PubMed ID: 18519085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ser-256 phosphorylation dynamics of Aquaporin 2 during maturation from the ER to the vesicular compartment in renal cells.
    Procino G; Carmosino M; Marin O; Brunati AM; Contri A; Pinna LA; Mannucci R; Nielsen S; Kwon TH; Svelto M; Valenti G
    FASEB J; 2003 Oct; 17(13):1886-8. PubMed ID: 12897058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M; Gilbert S; Rosenthal W
    Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
    Ishikawa SE
    Nihon Rinsho; 2002 Feb; 60(2):350-5. PubMed ID: 11857925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell surface rescue of kidney anion exchanger 1 mutants by disruption of chaperone interactions.
    Patterson ST; Reithmeier RAF
    J Biol Chem; 2010 Oct; 285(43):33423-33434. PubMed ID: 20628050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.